| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 39 |
| 1 | ETOPOSIDE | 29 |
| 2 | LAMIVUDINE | 26 |
| 3 | MELPHALAN HYDROCHLORIDE | 25 |
| 4 | LAMIVUDINE ORAL | 20 |
| 5 | RITONAVIR | 15 |
| 6 | RITONAVIR 100 MG | 13 |
| 7 | ZIDOVUDINE | 12 |
| 8 | MELPHALAN | 11 |
| 9 | NEVIRAPINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOPOTECAN | 9 | 0.0015 |
| 1 | DIAZOXIDE | 1 | 0.0014 |
| 2 | ZIDOVUDINE | 12 | 0.0012 |
| 3 | NEVIRAPINE | 10 | 0.0011 |
| 4 | LAMIVUDINE | 26 | 0.0010 |
| 5 | MELPHALAN HYDROCHLORIDE | 25 | 0.0010 |
| 6 | RITONAVIR 100 MG | 13 | 0.0009 |
| 7 | VERTEPORFIN FOR INJECTION | 1 | 0.0007 |
| 8 | ATAZANAVIR | 8 | 0.0006 |
| 9 | ETOPOSIDE | 29 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 26 | 0.0005 |
| 1 | Topoisomerase Inhibitor [EPC] | 34 | 0.0004 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0004 |
| 3 | Protease Inhibitor [EPC] | 15 | 0.0003 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 30 | 0.0003 |
| 5 | Photoenhancer [EPC] | 1 | 0.0003 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 15 | 0.0002 |
| 7 | Platinum-based Drug [EPC] | 39 | 0.0001 |
| 8 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |